Form: 3

Initial statement of beneficial ownership of securities

March 10, 2025

Documents

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Emerson Andrew
(Last) (First) (Middle)
ONE IDEXX DRIVE
(Street)
WESTBROOK ME 04092
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/01/2025 		3. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, CFO and Treasurer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 2,396.436 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) (1) Common Stock 61 (1) D
Restricted Stock Unit (2) (2) Common Stock 187 (2) D
Restricted Stock Unit (3) (3) Common Stock 125 (3) D
Restricted Stock Unit (4) (4) Common Stock 775 (4) D
Restricted Stock Unit (5) (5) Common Stock 258 (5) D
Incentive Stock Option (right-to-buy) (6) 02/13/2027 Common Stock 1,849 141.6 D
Incentive Stock Option (right-to-buy) (7) 02/13/2028 Common Stock 1,190 178.26 D
Non-Qualified Stock Option (right-to-buy) (8) 02/13/2029 Common Stock 586 206.94 D
Incentive Stock Option (right-to-buy) (9) 02/13/2029 Common Stock 515 206.94 D
Non-Qualified Stock Option (right-to-buy) (10) 02/13/2030 Common Stock 662 288.78 D
Incentive Stock Option (right-to-buy) (11) 02/13/2030 Common Stock 229 288.78 D
Non-Qualified Stock Option (right-to-buy) (12) 02/13/2031 Common Stock 230 544.08 D
Incentive Stock Option (right-to-buy) (13) 02/13/2031 Common Stock 183 544.08 D
Non-Qualified Stock Option (right-to-buy) (14) 02/13/2032 Common Stock 546 505.53 D
Incentive Stock Option (right-to-buy) (15) 02/13/2032 Common Stock 182 505.53 D
Non-Qualified Stock Option (right-to-buy) (16) 02/13/2033 Common Stock 703 497.43 D
Incentive Stock Option (right-to-buy) (17) 02/13/2033 Common Stock 217 497.43 D
Non-Qualified Stock Option (right-to-buy) (18) 02/13/2034 Common Stock 598 560.56 D
Incentive Stock Option (right-to-buy) (19) 02/13/2034 Common Stock 178 560.56 D
Non-Qualified Stock Option (right-to-buy) (20) 02/12/2035 Common Stock 4,383 459.76 D
Incentive Stock Option (right-to-buy) (21) 02/12/2035 Common Stock 217 459.76 D
Explanation of Responses:
1. Remainder of a grant of 247 restricted stock units ('RSU'). Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2023.
2. Remainder of a grant of 377 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2024.
3. Remainder of a grant of 167 RSUs. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.
4. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2026.
5. RSU grant that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2026.
6. Grant of option to buy 1,849 shares of Issuer common stock that vested on February 14, 2022.
7. Grant of option to buy 1,190 shares of Issuer common stock that vested on February 14, 2023.
8. Grant of option to buy 586 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2020.
9. Grant of option to buy 515 shares of Issuer common stock that vested on February 14, 2024.
10. Grant of option to buy 662 shares of Issuer common stock that vested in four annual installments beginning on February 14, 2021.
11. Grant of option to buy 229 shares of Issuer common stock that vested on February 14, 2025.
12. Grant of option to buy 230 shares of Issuer common stock that vested in four annual installments beginning on February 14, 2022.
13. Grant of option to buy 183 shares of Issuer common stock that vested on February 14, 2025.
14. Grant of option to buy 546 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2023.
15. Grant of option to buy 182 shares of Issuer common stock that vests on February 14, 2026.
16. Grant of option to buy 703 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2024.
17. Grant of option to buy 217 shares of Issuer common stock that vests on February 14, 2027.
18. Grant of option to buy 598 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2025.
19. Grant of option to buy 178 shares of Issuer common stock that vests on February 14, 2028.
20. Grant of option to buy 4,383 shares of Issuer common stock that vests in four annual installments beginning on February 14, 2026.
21. Grant of option to buy 217 shares of Issuer common stock that vests on February 14, 2029.
Remarks:
/s/ Andrew Emerson 03/10/2025
** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.